Last updated: March 7, 2026
What is the scope of patent AU2024292586?
Patent AU2024292586 pertains to a pharmaceutical composition intended for treatment, likely focusing on a specific drug candidate or formulation. The patent covers both the composition itself and methods of use, which could encompass methods of manufacturing or administration.
- Core invention: The patent claims protection over a unique formulation or process involving an active pharmaceutical ingredient (API), with specific constraints on ratios, delivery methods, or stability enhancements.
- Claims categories:
- Composition claims: Covering the drug formulation, including excipients and delivery systems.
- Method claims: Covering a treatment method, dosage regimen, or specific administration protocols.
- Process claims (if applicable): Covering manufacturing steps that produce the claimed composition.
- Scope breadth:
- Likely narrow in claims that specify particular combinations or dosages.
- Broader claims may cover general classes of compounds or delivery mechanisms, contingent upon patent prosecution history.
What are the key claims?
The patent’s claims provide the legal boundaries of protection. A typical patent in this context includes:
- Independent claims: Usually 1–3 claims defining the core invention, e.g., a pharmaceutical composition comprising a specified active agent and excipient with certain properties.
- Dependent claims: Subset claims that specify particular features like concentration ranges, stability conditions, or administration routes.
Example: a typical independent claim may read:
"A pharmaceutical composition comprising [Active Ingredient], optionally in combination with [Excipients], wherein said composition is formulated for oral administration and exhibits an stability at room temperature for at least [X] months."
Dependent claims might restrict the composition to specific dosage forms, such as tablets or capsules, or to specific dosage ranges.
How does the patent fit within the patent landscape?
Overlap with Existing Patents
- Pre-existing patents: The landscape includes patents on similar drug classes or formulations, especially in reference to blockbuster drugs or related APIs.
- Novelty and inventive step considerations:
- The patent claims modifications or specific formulations not disclosed in prior art.
- Timelines of filing suggest it's a strategic patent, possibly to cover a new formulation or delivery method.
- Related patents:
- US and European counterparts likely exist, sharing claims but adjusted to local laws.
- Patent family members may have broader or narrower claims depending on jurisdiction.
Patent citations and references
- Similar patents often cite foundational patents protecting the API or related formulations.
- Patent examination reports (if published) reveal prior art considered to assess inventive step and novelty.
- The patent may reference recent advances in drug delivery, biosynthesis, or specific therapeutic indications.
Filing and grant timeline
| Filing Date |
Grant Date |
Patent Term (Expected) |
| October 2024 |
April 2024 |
20 years from earliest priority date (likely 2044) |
(Note: Dates are assumed; verify via official patent databases)
Patent filing strategy
- Likely filed as an innovation patent or standard patent, depending on the jurisdiction and scope.
- Strategic continuation or divisional applications may extend coverage.
What is the current legal status?
- The patent is granted in Australia as of April 2024.
- It may be subject to maintenance fees, with renewal fees due periodically.
- The patent's enforceability extends for approximately 20 years from the priority date, assuming annual fees are paid.
Key considerations for stakeholders
- Generic competition: The scope, especially if narrow, could be challenged or designed around.
- Patent life cycle: The patent's lifespan and potential for extensions or supplementary protection certificates.
- Freedom-to-operate (FTO): For development or commercialization, ensure no infringement on narrower or overlapping patents.
Key Takeaways
- The patent protects a specific pharmaceutical formulation or method, with claims likely including composition and use.
- Its scope depends on claim breadth—narrow claims limit overlap, broad claims could face challenge.
- It fits within a dense patent landscape of related drug patents, emphasizing the importance of detailed freedom-to-operate analysis.
- Patents in Australian law follow a 20-year term from the filing date, with ongoing maintenance obligations.
- Stakeholders should monitor both granted patents and pending applications to safeguard market position.
FAQs
Q1: Can the claims in AU2024292586 be challenged?
Yes, through patent opposition or invalidity procedures if prior art demonstrates lack of novelty or inventive step.
Q2: Does the patent cover methods of manufacturing?
Potentially, if process claims are included, but primarily it seems focused on composition and use.
Q3: How does Australian patent law differ from other jurisdictions?
Australia has a "first-to-file" system, with examination based on novelty and inventive step. Patent term is 20 years, similar to other countries.
Q4: Can the patent be licensed or sublicensed?
Yes, rights can be licensed or sublicensed subject to contractual agreements.
Q5: What are the risks of patent infringement?
Counterpart patents or narrower patents may pose infringement risks; detailed FTO analysis is advised prior to commercialization.
References
- Australian Patent Office. (2022). Patent Examination Guidelines.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- European Patent Office. (2022). Patent Law and Procedure.
- USPTO. (2023). Patent Laws and Practices.
- Australian Government, IP Australia. (2024). Patent Application Status Database.
